Literature DB >> 20547712

Substituting placebo for established, effective therapy: why not?

Stan Shapiro1, Dean Fergusson, Kathleen Cranley Glass.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20547712      PMCID： PMC2972325          DOI： 10.1503/cmaj.090548

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  17 in total

1.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials.

Authors:  D Moher; K F Schulz; D G Altman
Journal:  Lancet       Date:  2001-04-14       Impact factor: 79.321

2.  What makes placebo-controlled trials unethical?

Authors:  Franklin G Miller; Howard Brody
Journal:  Am J Bioeth       Date:  2002       Impact factor: 11.229

Review 3.  Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials.

Authors:  Dean Fergusson; Kathleen Cranley Glass; Duff Waring; Stan Shapiro
Journal:  BMJ       Date:  2004-01-22

4.  Clinical trial registration: a statement from the International Committee of Medical Journal Editors.

Authors:  Catherine De Angelis; Jeffrey M Drazen; Frank A Frizelle; Charlotte Haug; John Hoey; Richard Horton; Sheldon Kotzin; Christine Laine; Ana Marusic; A John P M Overbeke; Torben V Schroeder; Hal C Sox; Martin B Van Der Weyden
Journal:  CMAJ       Date:  2004-09-14       Impact factor: 8.262

5.  Equipoise and the ethics of clinical research.

Authors:  B Freedman
Journal:  N Engl J Med       Date:  1987-07-16       Impact factor: 91.245

6.  Non-randomized controls in cancer clinical trials.

Authors:  E A Gehan; E J Freireich
Journal:  N Engl J Med       Date:  1974-01-24       Impact factor: 91.245

7.  Side effects and placebo amplification.

Authors:  R Thomson
Journal:  Br J Psychiatry       Date:  1982-01       Impact factor: 9.319

8.  Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1989-08-10       Impact factor: 91.245

9.  Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues.

Authors:  R Temple; S S Ellenberg
Journal:  Ann Intern Med       Date:  2000-09-19       Impact factor: 25.391

10.  Blinding in randomised trials: hiding who got what.

Authors:  Kenneth F Schulz; David A Grimes
Journal:  Lancet       Date:  2002-02-23       Impact factor: 79.321
View more
  2 in total

1.  Placebo orthodoxy and the double standard of care in multinational clinical research.

Authors:  Maya J Goldenberg
Journal:  Theor Med Bioeth       Date:  2015-02

2.  Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study.

Authors:  Kristian B Filion; Lisa M Lix; Oriana Hy Yu; Sophie Dell'Aniello; Antonios Douros; Baiju R Shah; Audray St-Jean; Anat Fisher; Eric Tremblay; Shawn C Bugden; Silvia Alessi-Severini; Paul E Ronksley; Nianping Hu; Colin R Dormuth; Pierre Ernst; Samy Suissa
Journal:  BMJ       Date:  2020-09-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.